The MedWise Risk Score™ is a quick and easy way to assess which patients are at highest risk for ADEs and require most immediate medication management attention. The MedWise Risk Score™ value is calculated using active medication ingredients of a patient’s entire medication profile, including over-the-counter medications (combination products’ individual active ingredients are analyzed).
In our study of almost one million patients, a risk score equal to or above 20 was found to be associated with increasingly higher medical expenditures, including for emergency department visits and hospitalizations. On average, of the cohorts for which we have performed Medication Risk Stratification, about 20% of patients over 65 have a medication risk score equal to or greater than 20, and thus are at high or very high risk for ADEs. For patients 64 and younger, on average, 7 – 10% are at high or very high risk.
We have also shown that focused collaboration with board-certified pharmacists can have a material effect in reducing these medication risk scores.